643
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Nonovert disseminated intravascular coagulation (DIC) in pregnancy: a new scoring system for the identification of patients at risk for obstetrical hemorrhage requiring blood product transfusion

, , , , , , ORCID Icon, , , , & ORCID Icon show all
Pages 242-257 | Received 12 Aug 2019, Accepted 12 Jan 2020, Published online: 03 Feb 2020

References

  • Rattray DD, O’Connell CM, Baskett TF. Acute disseminated intravascular coagulation in obstetrics: a tertiary centre population review (1980 to 2009). J Obstet Gynaecol Can. 2012;34(4):341–347.
  • Erez O, Novack L, Beer-Weisel R, et al. DIC score in pregnant women – a population based modification of the International Society on Thrombosis and Hemostasis score. PLoS One. 2014;9(4):e93240.
  • Wada H, Matsumoto T, Hatada T. Diagnostic criteria and laboratory tests for disseminated intravascular coagulation. Expert Rev Hematol. 2012;5(6):643–652.
  • Di Nisio M, Thachil J, Squizzato A. Management of disseminated intravascular coagulation: a survey of the International Society on Thrombosis and Haemostasis. Thromb Res. 2015;136(2):239–242.
  • Romero R. The management of acquired hemostatic failure during pregnancy. In: Berkowitz RL, editor. Critical care of the obstetric patient. New York: Churchill Livingstone; 1983. p. 219–284.
  • Taylor FB Jr., Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(11):1327–1330.
  • Egi M, Morimatsu H, Wiedermann CJ, et al. Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels. Thromb Haemost. 2009;101(4):696–705.
  • Fourrier F, Chopin C, Goudemand J, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest. 1992;101(3):816–823.
  • Levi M, ten Cate H, van der Poll T, et al. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA. 1993;270(8):975–979.
  • Gando S, Kameue T, Nanzaki S, et al. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost. 1996;75(2):224–228.
  • Levi M. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient. J Crit Care. 2001;16(4):167–177.
  • Lurie S, Feinstein M, Mamet Y. Disseminated intravascular coagulopathy in pregnancy: thorough comprehension of etiology and management reduces obstetricians’ stress. Arch Gynecol Obstet. 2000;263(3):126–130.
  • Levi M, de Jonge E, van der Poll T. Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis. 2003;16(1/2):43–47.
  • Gando S, Kameue T, Matsuda N, et al. Systemic inflammation and disseminated intravascular coagulation in early stage of ALI and ARDS: role of neutrophil and endothelial activation. Inflammation. 2004;28(4):237–244.
  • Levi M. Pathogenesis and treatment of DIC. Thromb Res. 2005;115(Suppl 1):54–55.
  • Cauchie P, Cauchie C, Boudjeltia KZ, et al. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital – meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation. Am J Hematol. 2006;81(6):414–419.
  • Levi M. Disseminated intravascular coagulation. Crit Care Med. 2007;35(9):2191–2195.
  • Gando S, Saitoh D, Ogura H, et al. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. Crit Care Med. 2008;36(1):145–150.
  • Levi M. Disseminated intravascular coagulation in cancer patients. Best Pract Res Clin Haematol. 2009;22(1):129–136.
  • Thachil J, Toh CH. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev. 2009;23(4):167–176.
  • Levi M. Disseminated intravascular coagulation (DIC) in pregnancy and the peri-partum period. Thromb Res. 2009;123(Suppl 2):S63–S64.
  • Montagnana M, Franchi M, Danese E, et al. Disseminated intravascular coagulation in obstetric and gynecologic disorders. Semin Thromb Hemost. 2010;36(04):404–418.
  • Romero R, Kadar N, Vaisbuch E, et al. Maternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection?. Am J Reprod Immunol. 2010;64(2):113–125.
  • Liao WC, Jaw FS. A noninvasive evaluation analysis of amniotic fluid embolism and disseminated intravascular coagulopathy. J Matern Fetal Neonatal Med. 2011;24(11):1411–1415.
  • Levi M, van der Poll T. Disseminated intravascular coagulation: a review for the internist. Intern Emerg Med. 2013;8(1):23–32.
  • Levi M. Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism). Thromb Res. 2013;131(Suppl 1):S32–S34.
  • Gasem T, Al Jama FE, Burshaid S, et al. Maternal and fetal outcome of pregnancy complicated by HELLP syndrome. J Matern Fetal Neonatal Med. 2009;22(12):1140–1143.
  • Hossain N, Paidas MJ. Disseminated intravascular coagulation. Semin Perinatol. 2013;37(4):257–266.
  • James AH, Cooper DL, Paidas MJ. Hemostatic assessment, treatment strategies, and hematology consultation in massive postpartum hemorrhage: results of a quantitative survey of obstetrician-gynecologists. Int J Womens Health. 2015;7:873–881.
  • Toh CH, Downey C. Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation. Blood Coagul Fibrinolysis. 2005;16(1):69–74.
  • Toh CH, Hoots WK, SSC on Disseminated Intravascular Coagulation of the ISTH. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost. 2007;5(3):604–606.
  • Lee JH, Song J. Diagnosis of non-overt disseminated intravascular coagulation made according to the International Society on Thrombosis and Hemostasis criteria with some modifications. Korean J Hematol. 2010;45(4):260–263.
  • Wada H, Hatada T, Okamoto K, et al. Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC. Am J Hematol. 2010;85(9):691–694.
  • Ronsmans C, Graham WJ. Lancet Maternal Survival Series steering group. Maternal mortality: who, when, where, and why. Lancet. 2006;368(9542):1189–1200.
  • Chong YS, Su LL. Misoprostol for preventing PPH: some lessons learned. Lancet. 2006;368(9543):1216–1218.
  • Hasegawa J, Sekizawa A, Tanaka H, et al. Current status of pregnancy-related maternal mortality in Japan: a report from the Maternal Death Exploratory Committee in Japan. BMJ Open. 2016;6(3):e010304.
  • Tanimia H, Jayaratnam S, Mola GL, et al. Near-misses at the Port Moresby General Hospital: a descriptive study. Aust N Z J Obstet Gynaecol. 2016;56(2):148–153.
  • Pacheco LD, Saade GR, Costantine MM, et al. An update on the use of massive transfusion protocols in obstetrics. Am J Obstet Gynecol. 2016;214(3):340–344.
  • Marshall AL, Durani U, Bartley A, et al. The impact of postpartum hemorrhage on hospital length of stay and inpatient mortality: a National Inpatient Sample-based analysis. Am J Obstet Gynecol. 2017;217(3):344.e1–344.e6.
  • Einerson BD, Son M, Schneider P, et al. The association between intrauterine balloon tamponade duration and postpartum hemorrhage outcomes. Am J Obstet Gynecol. 2017;216(3):300.e1–300.e5.
  • Borovac-Pinheiro A, Pacagnella RC, Cecatti JG, et al. Postpartum hemorrhage: new insights for definition and diagnosis. Am J Obstet Gynecol. 2018;219(2):162–168.
  • Brenner B, Aharon A, Lanir N. Hemostasis in normal pregnancy. Thromb Res. 2005;115(Suppl 1):6–10.
  • Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066–1074.
  • Paxton A, Wardlaw T. Are we making progress in maternal mortality? N Engl J Med. 2011;364(21):1990–1993.
  • Haeri S, Dildy GA. Maternal mortality from hemorrhage. Semin Perinatol. 2012;36(1):48–55.
  • Mariona FG. Does maternal obesity impact pregnancy-related deaths? Michigan experience. J Matern Fetal Neonatal Med. 2017;30(9):1060–1065.
  • Jonard M, Ducloy-Bouthors AS, Fourrier F. Comparison of two diagnostic scores of disseminated intravascular coagulation in pregnant women admitted to the ICU. PLoS One. 2016;11(11):e0166471.
  • Grossman KB, Arya R, Peixoto AB, et al. Maternal and pregnancy characteristics affect plasma fibrin monomer complexes and D-dimer reference ranges for venous thromboembolism in pregnancy. Am J Obstet Gynecol. 2016;215(4):466.e1–466.e8.
  • Hizkiyahu R, Rabinovich A, Thachil J, et al. Modified ISTH pregnancy-specific DIC score in parturients with liver rupture: population-based case series. J Matern Fetal Neonatal Med. 2019;32(15):2517–2523.
  • Hedengran KK, Andersen MR, Stender S, et al. Large D-dimer fluctuation in normal pregnancy: a longitudinal cohort study of 4,117 samples from 714 healthy Danish women. Obstet Gynecol Int. 2016;2016:1–7.
  • Hellgren M, Blombäck M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Invest. 1981;12(3):141–154.
  • Beller FK, Ebert C. The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium. Eur J Obstet Gynecol Reprod Biol. 1982;13(3):177–197.
  • Stirling Y, Woolf L, North WR, et al. Haemostasis in normal pregnancy. Thromb Haemost. 1984;52(2):176–182.
  • Donohoe S, Quenby S, Mackie I, et al. Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies. Lupus. 2002;11(1):11–20.
  • Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):153–168.
  • Guinn DA, Goldenberg RL, Hauth JC, et al. Risk factors for the development of preterm premature rupture of the membranes after arrest of preterm labor. Am J Obstet Gynecol. 1995;173(4):1310–1315.
  • Gomez R, Romero R, Edwin SS, et al. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect Dis Clin North Am. 1997;11(1):135–176.
  • Romero R, Friel LA, Velez Edwards DR, et al. A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). Am J Obstet Gynecol. 2010;203(4):361.e1–361.e30.
  • Myatt L, Miodovnik M. Prediction of preeclampsia. Semin Perinatol. 1999;23(1):45–57.
  • von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Preg. 2003;22(2):143–148.
  • Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785–799.
  • Than NG, Abdul Rahman O, Magenheim R, et al. Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. Virchows Arch. 2008;453(4):387–400.
  • Magee LA, Pels A, Helewa M, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014;36(5):416–441.
  • Ananth CV, Berkowitz GS, Savitz DA, et al. Placental abruption and adverse perinatal outcomes. JAMA. 1999;282(17):1646–1651.
  • Yeo L, Ananth C, Vintzileos AM, et al. Placental abruption. Glob Libr Women’s Med. 2008. doi:https://doi.org/10.3843/GLOWM.10122
  • Alexander GR, Himes JH, Kaufman RB, et al. A United States national reference for fetal growth. Obstet Gynecol. 1996;87(2):163–168.
  • Lu MC, Fridman M, Korst LM, et al. Variations in the incidence of postpartum hemorrhage across hospitals in California. Matern Child Health J. 2005;9(3):297–306.
  • Sheldon WR, on behalf of the WHO Multicountry Survey on Maternal and Newborn Health Research Network, Blum J, Vogel JP, et al. Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121(Suppl 1):5–13.
  • Kawakita T, Iqbal SN, Huang CC, et al. Nonmedically indicated induction in morbidly obese women is not associated with an increased risk of cesarean delivery. Am J Obstet Gynecol. 2017;217(4):451.e1–451.e8.
  • Coad SL, Dahlgren LS, Hutcheon JA. Risks and consequences of puerperal uterine inversion in the United States, 2004 through 2013. Am J Obstet Gynecol. 2017;217(3):377.e1–377.e6.
  • Lalonde A, FIGO Safe Motherhood and Newborn Health (SMNH) Committee, International Federation of Gynecology and Obstetrics. Prevention and treatment of postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet. 2012;117(2):108–118.
  • Marcellin L, Delorme P, Bonnet MP, et al. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta. Am J Obstet Gynecol. 2018;219(2):193.e1–193.e9.
  • Tsen LC. Management of coagulopathy. In: van de Velde M, Scholefled H, Plante L, editors. Maternal critical care. Cambridge: Cambridge University Press; 2013. p. 120–133.
  • Sina Haeri VC, Belfort MA. Obstetric hemorrhage. In: van de Velde M, Scholefled H, Plante L, editors. Maternal critical care. Cambridge: Cambridge University Press; 2013. p. 438–453.
  • Stevens W, Shih T, Incerti D, et al. Short-term costs of preeclampsia to the United States health care system. Am J Obstet Gynecol. 2017;217(3):237–248.e16.
  • Chhabra P, Guleria K, Saini NK, et al. Pattern of severe maternal morbidity in a tertiary hospital of Delhi, India: a pilot study. Trop Doct. 2008;38(4):201–204.
  • Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Preg Childbirth. 2009;9:55.
  • Souza JP, Gülmezoglu AM, Vogel J, et al. Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study. Lancet. 2013;381(9879):1747–1755.
  • Maswime S, Buchmann E. A systematic review of maternal near miss and mortality due to postpartum hemorrhage. Int J Gynecol Obstet. 2017;137(1):1–7.
  • Filippi V, Ronsmans C, Gohou V, et al. Maternity wards or emergency obstetric rooms? Incidence of near-miss events in African hospitals. Acta Obstet Gynecol Scand. 2005;84(1):11–16.
  • Walfish M, Neuman A, Wlody D. Maternal haemorrhage. Br J Anaesth. 2009;103(Suppl 1):i47–i56.
  • Khosla AH, Dahiya K, Sangwan K. Maternal mortality and “near-miss” in rural north India. Int J Gynaecol Obstet. 2000;68(2):163–164.
  • Gyamfi-Bannerman C, Srinivas SK, Wright JD, et al. Postpartum hemorrhage outcomes and race. Am J Obstet Gynecol. 2018;219(2):185.e1–185.e10.
  • Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–e333.
  • Creanga AA, Syverson C, Seed K, et al. Pregnancy-related mortality in the United States, 2011–2013. Obstet Gynecol. 2017;130(2):366–373.
  • Lewis G. Emerging lessons from the FIGO LOGIC initiative on maternal death and near-miss reviews. Int J Gynaecol Obstet. 2014;127(Suppl 1):S17–S20.
  • El-Refaey H, Rodeck C. Post-partum haemorrhage: definitions, medical and surgical management. A time for change. Br Med Bull. 2003;67(1):205–217.
  • Janes SL, Goodall AH. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy. Clin Sci (Lond). 1994;86(6):731–739.
  • Brown MA. The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol. 1995;22(11):781–791.
  • Ozimek JA, Eddins RM, Greene N, et al. Opportunities for improvement in care among women with severe maternal morbidity. Am J Obstet Gynecol. 2016;215(4):509.e1–509.e6.
  • Linehan LA, Walsh J, Morris A, et al. Neonatal and maternal outcomes following midtrimester preterm premature rupture of the membranes: a retrospective cohort study. BMC Preg Childbirth. 2016;16:25.
  • Bellart J, Gilabert R, Fontcuberta J, et al. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation. Amer J Perinatol. 1998;15(02):81–85.
  • Voigt LF, Hollenbach KA, Krohn MA, et al. The relationship of abruptio placentae with maternal smoking and small for gestational age infants. Obstet Gynecol. 1990;75(5):771–774.
  • Clark SL, Romero R, Dildy GA, et al. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol. 2016;215(4):408–412.
  • Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol. 2015;213(4):452–463.
  • Brenner B. Haemostatic changes in pregnancy. Thromb Res. 2004;114(5-6):409–414.
  • Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114(6):1326–1331.
  • Cunningham FG, Nelson DB. Disseminated intravascular coagulation syndromes in obstetrics. Obstet Gynecol. 2015;126(5):999–1011.
  • Collis RE, Collins PW. Haemostatic management of obstetric haemorrhage. Anaesthesia. 2015;70(Suppl 1):78–86. e27.
  • Hui C, Lili M, Libin C, et al. Changes in coagulation and hemodynamics during pregnancy: a prospective longitudinal study of 58 cases. Arch Gynecol Obstet. 2012;285(5):1231–1236.
  • Jeremiah ZA, Adias TC, Opiah M, et al. Elevation in D-dimer concentrations is positively correlated with gestation in normal uncomplicated pregnancy. Int J Womens Health. 2012;4:437–443.
  • Réger B, Péterfalvi A, Litter I, et al. Challenges in the evaluation of D-dimer and fibrinogen levels in pregnant women. Thromb Res. 2013;131(4):e183–e187.
  • Choi JW, Pai SH. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy. Ann Hematol. 2002;81(11):611–615.
  • Erez O. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol. 2017;217(2):228–229.
  • Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5(2):266–273.
  • Kobayashi T, Terao T. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers. Gynecol Obstet Invest. 1987;24(3):170–178.
  • de Boer K, ten Cate JW, Sturk A, et al. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol. 1989;160(1):95–100.
  • Reinthaller A, Mursch-Edlmayr G, Tatra G. Thrombin-antithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery. BJOG. 1990;97(6):506–510.
  • Elovitz MA, Baron J, Phillippe M. The role of thrombin in preterm parturition. Am J Obstet Gynecol. 2001;185(5):1059–1063.
  • Rosen T, Kuczynski E, O'Neill LM, et al. Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes. J Maternal-Fetal Neonatal Med. 2001;10(5):297–300.
  • Chaiworapongsa T, Espinoza J, Yoshimatsu J, et al. Activation of coagulation system in preterm labor and preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 2002;11(6):368–373.
  • Chaiworapongsa T, Yoshimatsu J, Espinoza J, et al. Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia. J Matern Fetal Neonatal Med. 2002;11(6):362–367.
  • Erez O, Gotsch F, Mazaki-Tovi S, et al. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death. J Matern Fetal Neonatal Med. 2009;22(8):672–687.
  • Hansen AT, Andreasen BH, Salvig JD, et al. Changes in fibrin D-dimer, fibrinogen, and protein S during pregnancy. Scand J Clin Lab Invest. 2011;71(2):173–176.
  • Larsson C, Saltvedt S, Wiklund I, et al. Estimation of blood loss after cesarean section and vaginal delivery has low validity with a tendency to exaggeration. Acta Obstet Gynecol Scand. 2006;85(12):1448–1452.
  • Brant HA. Precise estimation of postpartum haemorrhage: difficulties and importance. Br Med J. 1967;1(5537):398–400.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.